Profil Tekanan Darah dan Kejadian ESO Pasien Penerima Monoterapi Antihipertensi di Puskesmas Kabupaten Banyumas

Authors

  • Aulia Rahman Program Studi Farmasi Fakultas Sains dan Teknologi Universitas Peradaban
  • Luthfi Hidayat Maulana Program Studi Farmasi Fakultas Sains dan Teknologi Universitas Peradaban
  • Syaiful Prayogi Program Studi Farmasi Fakultas Sains dan Teknologi Universitas Peradaban http://orcid.org/0000-0002-6140-6480

DOI:

https://doi.org/10.25273/pharmed.v5i1.11998

Keywords:

amlodipine, candesartan, lisinopril, monotherapy, antihypertensi

Abstract

Hypertension is a cardiovascular disease with the highest prevalence. JNC VIII categorizes hypertension if blood pressure > 140/90 mmHg. This study aims to determine the patient's profile, blood pressure, and the possible incidence of ESO in patients receiving antihypertensive monotherapy in Banyumas Regency, the eastern region. The study was conducted retrospectively. Samples were carried out using total sampling. The sample size in this study was 44 patients. The highest number of patients was female, i.e. 82%, with the majority having primary education/equivalent. The monotherapy used was Amlodipine (class CCBs), Candesartan (class ARB), and Lisinopril (class ACEI) with the highest number of prescriptions being Amlodipine (70.5%). The incidence of ESO that is often experienced is dizziness by 6.8%. There was no significant difference in the effectiveness of each monotherapy used with Asymp. Sig = 0.666 (for systolic pressure) and 0.716 (for diastolic pressure). 

Downloads

Download data is not yet available.

References

(AHA), A. H. A. (2014). Understanding and Controlling Your High Blood pressure (Krames Staywell (ed.)).

Alfian, R., Susanto, Y. and Khadijah, S. (2017). kualitas Hidup Pasien Hipertensi Dengan Penyakit Penyerta Di Poli Jantung RSUD Ratu Zalecha Martapura. Pharmascience, 04(01), 39–47.

Anggara, F. H. D., & Prayitno, N. (2013). Faktor-Faktor Yang Berhubungan dengan Tekanan Darah Di Puskesmas Telaga Murni, Cikarang Barat Tahun 2012. Jurnal Ilmiah Kesehatan, 5(1), 20–25.

Anwar, K., & Masnina, R. (2019). Hubungan Kepatuhan Minum Obat Antihipertensi denganTekanan Darah Pada Lansia Penderita Hipertensi di Wilayah Kerja Puskesmas Air Putih Samarinda. Borneo Student Research (BSR), 1(1), 494–501. https://journals.umkt.ac.id/index.php/bsr/article/view/939

Bhagani, S., Kapil, V., & Lobo, M. D. (2018). Hypertension. Medicine, 46(9), 509–515. https://doi.org/10.1016/j.mpmed.2018.06.009

Dinkes. (2016). Profil Kesehatan Banyumas.

Fung, V., Huang, J., Brand, R., Newhouse, J. P., & Hsu, J. (2007). Hypertension treatment in a medicare population: Adherence and systolic blood pressure control. Clinical Therapeutics, 29(5), 972–984. https://doi.org/10.1016/J.CLINTHERA.2007.05.010

Hairunisa, H. (Hairunisa). (2014). Hubungan Tingkat Kepatuhan Minum Obat dan Diet dengan Tekanan Darah Terkontrol pada Penderita Hipertensi Lansia di Wilayah Kerja Puskesmas Perumnas I Kecamatan Pontianak Barat. Jurnal Mahasiswa Fakultas Kedokteran Untan, 1(1), 189138. https://doi.org/10.0/CSS/ALL.CSS

Hendarti, H. F. (2016). Evaluasi Ketepatan Obat dan Dosis Obat Antihipertensi pada Pasien Hipertensi Rawat Jalan di Puskesmas Ciputat Januari-Maret 2015. Universitas Islamnegeri Syarif Hidayatullah Jakarta.

Indonesia, D. K. R. (2007). Riset kesehatan dasar(Riskesdas).

Indonesian, D. K. (2018). Riset Kesehatan Dasar.

Jateng, D. K. P. (2015). Profil Kesehatan Jawa Tengah.

Luh, N., Ekarini, P., Wahyuni, J. D., Sulistyowati, D., Keperawatan, J., Kemenkes, P., & Iii, J. (2020). Faktor - Faktor Yang Berhubungan Dengan Hipertensi Pada Usia Dewasa. JKEP, 5(1), 61–73. https://doi.org/10.32668/JKEP.V5I1.357

Nafrialdi. (2012). “Antihipertensiâ€. Farmakologi dan Terapi Edisi 5 (Edisi 5). Departemen Farmakologik dan Terapeutik Fakultas Kedokteran Universitas Indonesia.

Naidu M U R, Usha P R, R. K. R. T. (2000). Evaluation of amlodipin, lisinopril and a combination in the treatment of eesential hypertension. Postgrad Med, 76, 350–353.

Puspita, A., Aisah, S., & -, S. (2012). SIKAP TERHADAP KEPATUHAN DIIT HIPERTENSI DENGAN TEKANAN DARAH PADA PENDERITA HIPERTENSI DI WILAYAH KERJA PUSKESMAS DORO II KABUPATEN PEKALONGAN. FIKkeS, 5(1). https://jurnal.unimus.ac.id/index.php/FIKkeS/article/view/1855

Resmi, S. P. O. (2018). Evaluasi Rasionalitas Penggunaan Obat Antihipertensi pada Pasien Hipertensi di Instalasi Rawat Inap Rsud Ir. Soekarno Kabupaten Sukoharjo Tahun 2016 [Universitas Setia Budi, Surakarta]. https://doi.org/10.1542/peds.2006-2099

Supraptia. B., et all. (2014). ). Permasalahan terkait obat antihipertensi pada Pasien Usia Lanjut di Poli Geriatri RSUD Dr. Soetomo, Surabaya. Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia, Volume1(2), 36–41.

Supraptia, B. et al. (2014). Permasalahan Terkait Obat Antihipertensi pada Pasien Usia Lanjut di Poli Geriatri RSUD Dr.Soetomo Surabaya. Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia, 1(2), 36–41.

Tandililing, S., Mukaddas, A., & Faustine, I. (2017). Profil Penggunaan Obat Pasien Hipertensi Esensial di Instalasi Rawat Jalan Rumah Sakit Umum Daerah I Lagaligo Kabupaten Luwu Timur Periode Januari-Desember Tahun 2014. GALENIKA Journal of Pharmacy, 3(1), 49–56.

Wicaksono, S. (2019). ANGKA KEJADIAN PENINGKATAN TEKANAN DARAH (HIPERTENSI) PADA LANSIA DI DUSUN 1 DESA KEMBANGSERI KECAMATAN TALANG EMPAT BENGKULU TENGAH TAHUN 2015. Jurnal Kedokteran Raflesia, 5(1), 1–6. https://doi.org/10.33369/JUKE.V5I1.8765

Winarno, T., Utami, P. I., & Setiawan, D. (2021). PERBANDINGAN EFEK TERAPI ANTIHIPERTENSI PADA PASIEN PROLANIS DI KABUPATEN BANYUMAS. Parapemikir : Jurnal Ilmiah Farmasi, 10(2), 13–20. https://doi.org/10.30591/pjif.v10i2.2142

Yulanda, G., & Lisiswanti, R. (2017). Penatalaksanaan Hipertensi Primer. Majority, 6(1), 25–33.

Downloads

Additional Files

Published

2022-05-13

Issue

Vol. 5 No. 1 (2022)

Section

Articles

License

With the receipt of the article by Pharmed Editorial Board and the decision to be published, the copyright regarding the article will be transferred to Pharmed Journal.

Pharmed has the right to multiply and distribute the article and every author is not allowed to publish the same article that was published in this journal.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Under the following terms:

Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

NonCommercial — You may not use the material for commercial purposes.

ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.